MediPal (TYO:7459) raised its interim and final dividend forecasts for the fiscal year ending March 31, 2027, to 44 yen each, from 34 yen previously, following the completion of the tender offer for Paltac's (TYO:8283) shares.
The revised annual dividend of 88 yen per share is higher than the 66 yen per share paid in the prior fiscal year, according to a Tokyo bourse filing on Tuesday.
The dividend is payable from retained earnings, with specific payment dates to be determined.
The company's basic policy targets enhancing shareholder returns based on improved profit levels following the transition of Paltac into a wholly owned subsidiary.